Spinal Tech

Zimmer Biomet posted $1.8 billion in net sales in the first quarter of 2021 and expects to see up to 17 percent revenue growth this year.

Devicemaker SeaSpine posted $42 million in first quarter revenue, a 16 percent increase compared to the same period in 2020.

Sacropelvic device company SI-Bone reported May 3 that first-quarter revenue increased 22 percent year over year to $20.4 million.

Although Smith+Nephew's overall first quarter revenue has grown since the same period in 2019, orthopedic revenue is still catching up to pre-pandemic figures.

CMS has proposed extending new technology add-on payments for technologies that would otherwise be discontinued in fiscal year 2022.

Orthofix net sales grew in the first quarter, driven by strong U.S. spinal implant sales.

Medical device company Conventus-Flower Orthopedics partnered with Red One Medical, a private sector scout for the Department of Veterans Affairs and Department of Defense.

Smith+Nephew posted $1.3 billion in first-quarter revenue, an 11.5 percent year over-year-increase, with significant growth in hip sales.

Here are seven updates from spine and orthopedic device companies in the last week:

Despite the COVID-19 pandemic, Stryker continued financial growth and has posted gains in its spine and neurotechnology segment since 2019. While the orthopedic segment has grown overall since 2019, the increase was most apparent in trauma and extremities sales.